Additional eculizumab dose and tacrolimus discontinuation for treatment of COVID-19 in a kidney transplant recipient with aHUS

Ther Apher Dial. 2022 Feb;26(1):250-251. doi: 10.1111/1744-9987.13710. Epub 2021 Jul 24.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • COVID-19*
  • Humans
  • Kidney Transplantation*
  • SARS-CoV-2
  • Tacrolimus

Substances

  • Antibodies, Monoclonal, Humanized
  • eculizumab
  • Tacrolimus